Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-14 Purchase | 2026-01-16 4:01 pm | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 8,832 | $1.6983 | $14,999 | 20,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-01 Option Award | 2026-03-03 4:19 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 132,925 | $0 | 132,925 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-05 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 1,164 | $1.26 | 12,151 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:30 pm | N/A 2035-03-31 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 35,209 | $0 | 35,209 (Direct) | View |
Ownership | 2025-04-03 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 0 | $0 | 169,340 (Direct) | View |